omega-3 ethyl ester 90

Known as: P-OM3 adjunct 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2018
0246820062018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The metabolic syndrome includes both dyslipidemia and impaired vascular function. Because extended-release niacin (ERN) and… (More)
Is this relevant?
2011
2011
Patients with increased triglyceride levels compared to those with normal levels are at higher risk for coronary heart disease… (More)
Is this relevant?
2009
2009
BACKGROUND Prescription omega-3-acid ethyl esters (P-OM3) often are used for hypertriglyceridemic patients receiving statin… (More)
Is this relevant?
2009
2009
BACKGROUND Atrial fibrillation (AF) continues to be one of the most common cardiac problems, placing an expanding burden on the… (More)
Is this relevant?
2009
2009
Preclinical and clinical studies demonstrate that the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2008
2008
Omega-3 fatty acids (n-3 FA) from oily fish are clinically useful for lowering triglycerides and reducing risk of heart attacks… (More)
Is this relevant?
2008
2008
Prescription omega-3 acid ethyl esters (P-OM3) are commonly used for treatment of very high triglyceride levels, often in… (More)
Is this relevant?
2008
2008
BACKGROUND Prescription omega-3-acid ethyl esters (P-OM3) have been used as adjunctive therapy to statin drugs in patients with… (More)
Is this relevant?
2008
2008
BACKGROUND Patients with persistent hypertriglyceridemia while on statin therapy may require adjunctive lipid-lowering therapy to… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Patients with elevated serum triglyceride (TG) levels often have elevations in non-high-density lipoprotein… (More)
Is this relevant?